The Muscular Dystrophy Association (MDA) is honoring a longtime researcher and an LGMD patient advocate with its 2025 Legacy ...

The United States Patent and Trademark Office recently issued patent 12,178,937 entitled “Compositions and Methods for ...

Mitchell Kapoor, an analyst from H.C. Wainwright, reiterated the Sell rating on Sarepta Therapeutics (SRPT – Research Report). The associated ...

Gary Young, the PGA Tour’s senior vice president of rules and competition, said players and fans have suggested they could ...

BOSTON - PepGen Inc. (NASDAQ: PEPG), a biotechnology firm focused on oligonucleotide therapies for severe neuromuscular and neurological diseases, is progressing with its CONNECT clinical program for ...

PepGen Inc. , a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological ...

El Paso Electric is using an integrated data access solution from Oracle and UtilityAPI that is intended to meet the Green ...

Top-line Phase 3 trial data show ambulatory boys with Duchenne continued with motor improvements two years after a single ...

The announcement was made at Arab Health 2025 where Sidra Medicine will highlight its international patient service programmes ...

Sidra Medicine, a member of Qatar Foundation, has established a gene therapy centre to treat rare genetic diseases such as ...

In year two of the trial, Elevidys demonstrated statistically significant and clinically improvements across three key ...

The Anti-Corruption Commission has filed a case against 52 people, including Ahsanul Alam, former Islami Bank chairman and ...